227 related articles for article (PubMed ID: 22777139)
1. Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.
Rettori E; De Laurentiis A; Zorrilla Zubilete M; Rettori V; Elverdin JC
Neuroimmunomodulation; 2012; 19(5):293-303. PubMed ID: 22777139
[TBL] [Abstract][Full Text] [Related]
2. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
3. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
de Morais H; de Souza CP; da Silva LM; Ferreira DM; Baggio CH; Vanvossen AC; Cristina de Carvalho M; da Silva-Santos JE; Bertoglio LJ; Cunha JM; Zanoveli JM
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1590-600. PubMed ID: 27544303
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin alleviates periodontitis in adult rats.
Dmytrenko G; Fernández-Solari J; Correa F; De Laurentiis A
J Periodontal Res; 2024 Apr; 59(2):280-288. PubMed ID: 38226427
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats.
Ossola CA; Surkin PN; Pugnaloni A; Mohn CE; Elverdin JC; Fernandez-Solari J
Inflamm Res; 2012 Sep; 61(9):941-8. PubMed ID: 22581275
[TBL] [Abstract][Full Text] [Related]
7. The histopathological and morphometric investigation of the effects of systemically administered humic acid on alveolar bone loss in ligature-induced periodontitis in rats.
Çalışır M; Akpınar A; Poyraz Ö; Göze F; Çınar Z
J Periodontal Res; 2016 Aug; 51(4):499-507. PubMed ID: 26547279
[TBL] [Abstract][Full Text] [Related]
8. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion.
Fernandez-Solari J; Prestifilippo JP; Ossola CA; Rettori V; Elverdin JC
Arch Oral Biol; 2010 Aug; 55(8):583-90. PubMed ID: 20542488
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat Attenuates the Progression of Periodontitis in Rats.
Nessa N; Kobara M; Toba H; Adachi T; Yamamoto T; Kanamura N; Pezzotti G; Nakata T
Pharmacology; 2021; 106(5-6):294-304. PubMed ID: 33735887
[TBL] [Abstract][Full Text] [Related]
10. Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model.
Dong Y; Huihui Z; Li C
J Periodontal Res; 2015 Dec; 50(6):758-65. PubMed ID: 25736698
[TBL] [Abstract][Full Text] [Related]
11. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Guindon J; De Léan A; Beaulieu P
Pain; 2006 Mar; 121(1-2):85-93. PubMed ID: 16480822
[TBL] [Abstract][Full Text] [Related]
12. Denervation effectively aggravates rat experimental periodontitis.
Yu X; Gong Z; Lin Q; Wang W; Liu S; Li S
J Periodontal Res; 2017 Dec; 52(6):1011-1020. PubMed ID: 28621056
[TBL] [Abstract][Full Text] [Related]
13. Effects of calcium gluconate on experimental periodontitis and alveolar bone loss in rats.
Ku SK; Cho HR; Sung YS; Kang SJ; Lee YJ
Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):241-50. PubMed ID: 21118355
[TBL] [Abstract][Full Text] [Related]
14. Effects of Polycan, a β-glucan, on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats.
Kim YS; Kang SJ; Kim JW; Cho HR; Moon SB; Kim KY; Lee HS; Han CH; Ku SK; Lee YJ
J Periodontal Res; 2012 Dec; 47(6):800-10. PubMed ID: 22780690
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
16. Chronic stress adaptation of the nitric oxide synthases and IL-1β levels in brain structures and hypothalamic-pituitary-adrenal axis activity induced by homotypic stress.
Gadek-Michalska A; Tadeusz J; Rachwalska P; Bugajski J
J Physiol Pharmacol; 2015 Jun; 66(3):427-40. PubMed ID: 26084225
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
18. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Hernangómez M; Mestre L; Correa FG; Loría F; Mecha M; Iñigo PM; Docagne F; Williams RO; Borrell J; Guaza C
Glia; 2012 Sep; 60(9):1437-50. PubMed ID: 22653796
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.
Abidi AH; Presley CS; Dabbous M; Tipton DA; Mustafa SM; Moore BM
Arch Oral Biol; 2018 Mar; 87():79-85. PubMed ID: 29274621
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
